169 related articles for article (PubMed ID: 20021961)
1. [Relationship between epithelial-mesenchymal transition and basal cell-like phenotype in breast cancer].
Wu WX; Zhang YP; Wen XW; Lu N; Tang ZY; Zhang Y; Wang Z; Wang W; Yang HJ
Zhonghua Bing Li Xue Za Zhi; 2009 Aug; 38(8):519-23. PubMed ID: 20021961
[TBL] [Abstract][Full Text] [Related]
2. Dysregulated expression of Slug, vimentin, and E-cadherin correlates with poor clinical outcome in patients with basal-like breast cancer.
Liu T; Zhang X; Shang M; Zhang Y; Xia B; Niu M; Liu Y; Pang D
J Surg Oncol; 2013 Feb; 107(2):188-94. PubMed ID: 22886823
[TBL] [Abstract][Full Text] [Related]
3. P-cadherin and vimentin are useful basal markers in breast cancers.
Tsang JY; Au SK; Ni YB; Shao MM; Siu WM; Hui SW; Chan SK; Chan KW; Kwok YK; Chan KF; Tse GM
Hum Pathol; 2013 Dec; 44(12):2782-91. PubMed ID: 24139214
[TBL] [Abstract][Full Text] [Related]
4. Epithelial-mesenchymal transition increases during the progression of in situ to invasive basal-like breast cancer.
Choi Y; Lee HJ; Jang MH; Gwak JM; Lee KS; Kim EJ; Kim HJ; Lee HE; Park SY
Hum Pathol; 2013 Nov; 44(11):2581-9. PubMed ID: 24055090
[TBL] [Abstract][Full Text] [Related]
5. [Expression of Twist, E-cadherin and N-cadherin in breast carcinoma and their clinical significance].
Ma YH; Wang K; Li L; Lu ZH; Chen J
Zhonghua Bing Li Xue Za Zhi; 2010 Jan; 39(1):5-9. PubMed ID: 20388391
[TBL] [Abstract][Full Text] [Related]
6. Epithelial Paradox: Clinical Significance of Coexpression of E-cadherin and Vimentin With Regard to Invasion and Metastasis of Breast Cancer.
Yamashita N; Tokunaga E; Iimori M; Inoue Y; Tanaka K; Kitao H; Saeki H; Oki E; Maehara Y
Clin Breast Cancer; 2018 Oct; 18(5):e1003-e1009. PubMed ID: 29526677
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of epithelial-mesenchymal transition-related markers between cancer tissue and tumor emboli].
He N; Wu GF; Zhao HY; Han HX
Zhonghua Bing Li Xue Za Zhi; 2011 Nov; 40(11):758-61. PubMed ID: 22336160
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer-associated fibroblasts induce epithelial-to-mesenchymal transition in breast cancer cells.
Soon PS; Kim E; Pon CK; Gill AJ; Moore K; Spillane AJ; Benn DE; Baxter RC
Endocr Relat Cancer; 2013 Feb; 20(1):1-12. PubMed ID: 23111755
[TBL] [Abstract][Full Text] [Related]
9. [Expression of FOXC-2 and YB-1 in Gastric Carcinoma and Its Role in Invasion and Metastasis].
Jin X; Qian J; Yu DJ; Guo CX; Li N; Zhu Q; Zhao Y
Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Mar; 49(2):215-220. PubMed ID: 29737063
[TBL] [Abstract][Full Text] [Related]
10. FOXF2 suppresses the FOXC2-mediated epithelial-mesenchymal transition and multidrug resistance of basal-like breast cancer.
Cai J; Tian AX; Wang QS; Kong PZ; Du X; Li XQ; Feng YM
Cancer Lett; 2015 Oct; 367(2):129-37. PubMed ID: 26210254
[TBL] [Abstract][Full Text] [Related]
11. Implications of the Notch1-Snail/Slug-epithelial to mesenchymal transition axis for lymph node metastasis in infiltrating ductal carcinoma.
Cao YW; Wan GX; Sun JP; Cui XB; Hu JM; Liang WH; Zheng YQ; Li WQ; Li F
Kaohsiung J Med Sci; 2015 Feb; 31(2):70-6. PubMed ID: 25645984
[TBL] [Abstract][Full Text] [Related]
12. Combination of epithelial-mesenchymal transition and cancer stem cell-like phenotypes has independent prognostic value in gastric cancer.
Ryu HS; Park DJ; Kim HH; Kim WH; Lee HS
Hum Pathol; 2012 Apr; 43(4):520-8. PubMed ID: 22018628
[TBL] [Abstract][Full Text] [Related]
13. P-cadherin, vimentin and CK14 for identification of basal-like phenotype in breast carcinomas: an immunohistochemical study.
Sousa B; Paredes J; Milanezi F; Lopes N; Martins D; Dufloth R; Vieira D; Albergaria A; Veronese L; Carneiro V; Carvalho S; Costa JL; Zeferino L; Schmitt F
Histol Histopathol; 2010 Aug; 25(8):963-74. PubMed ID: 20552547
[TBL] [Abstract][Full Text] [Related]
14. Syndecan-1 overexpression is associated with nonluminal subtypes and poor prognosis in advanced breast cancer.
Nguyen TL; Grizzle WE; Zhang K; Hameed O; Siegal GP; Wei S
Am J Clin Pathol; 2013 Oct; 140(4):468-74. PubMed ID: 24045542
[TBL] [Abstract][Full Text] [Related]
15. The clinicopathological significance of CD44+/CD24-/low and CD24+ tumor cells in invasive micropapillary carcinoma of the breast.
Li W; Liu F; Lei T; Xu X; Liu B; Cui L; Wei J; Guo X; Lang R; Fan Y; Gu F; Tang P; Zhang X; Fu L
Pathol Res Pract; 2010 Dec; 206(12):828-34. PubMed ID: 20977976
[TBL] [Abstract][Full Text] [Related]
16. Basal-like breast cancer defined by FOXC1 expression offers superior prognostic value: a retrospective immunohistochemical study.
Ray PS; Bagaria SP; Wang J; Shamonki JM; Ye X; Sim MS; Steen S; Qu Y; Cui X; Giuliano AE
Ann Surg Oncol; 2011 Dec; 18(13):3839-47. PubMed ID: 21424368
[TBL] [Abstract][Full Text] [Related]
17. GATA3 expression and its relationship with clinicopathological parameters in invasive breast carcinomas.
Cakir A; Isik Gonul I; Ekinci O; Cetin B; Benekli M; Uluoglu O
Pathol Res Pract; 2017 Mar; 213(3):227-234. PubMed ID: 28215639
[TBL] [Abstract][Full Text] [Related]
18. Relationships between immunophenotype, Ki-67 index, microvascular density, Ep-CAM/P-cadherin, and MMP-2 expression in early-stage invasive ductal breast cancer.
Niemiec JA; Adamczyk A; Małecki K; Majchrzyk K; Ryś J
Appl Immunohistochem Mol Morphol; 2012 Dec; 20(6):550-60. PubMed ID: 22531681
[TBL] [Abstract][Full Text] [Related]
19. FOXF2 deficiency promotes epithelial-mesenchymal transition and metastasis of basal-like breast cancer.
Wang QS; Kong PZ; Li XQ; Yang F; Feng YM
Breast Cancer Res; 2015 Feb; 17(1):30. PubMed ID: 25848863
[TBL] [Abstract][Full Text] [Related]
20. c-Kit expression as a prognostic molecular marker in patients with basal-like breast cancer.
Kashiwagi S; Yashiro M; Takashima T; Aomatsu N; Kawajiri H; Ogawa Y; Onoda N; Ishikawa T; Wakasa K; Hirakawa K
Br J Surg; 2013 Mar; 100(4):490-6. PubMed ID: 23319435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
